ELAN — Elanco Animal Health Incorporated Share News
0.000.00%
Last trade - 00:00- $11.76bn
- $15.15bn
- $4.72bn
Brief: FDA Issues Emergency Use Authorization For Credelio Cat To Treat New World Screwworm In Cats
Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats
Elanco Animal Health rises as KeyBanc joins bull camp
U.S. RESEARCH ROUNDUP-Bath & Body Works, Elastic, Walmart
U.S. RESEARCH ROUNDUP- Bath & Body Works, Elastic, Walmart
Elanco Animal Health beats Q3 revenue, profit estimates; hikes FY forecast
Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms
Brief: Elanco’s Credelio Gets First FDA Emergency Use Nod Against New World Screwworm in Dogs
Advantix-maker Elanco must face some price-fixing claims over flea, tick products
Acadia Healthcare names Todd Young as CFO amid activist investor pressure
Brief: Acadia Healthcare Appoints Todd Young As Chief Financial Officer
U.S. RESEARCH ROUNDUP- BlackRock, Goldman Sachs, Netflix
Performance Food settles with Sachem Head, hands seat to Ferguson (updated)
Performance Food says Sachem Head's Ferguson joins board
U.S. STOCKS ON THE MOVE-Energy stocks, Primerica, Micron Technology
U.S. STOCKS ON THE MOVE-Clean energy stocks, Energy stocks, McKesson
U.S. STOCKS ON THE MOVE-Boeing, gold miners, silver miners
Elanco rises on label update for its skin disease treatment for dogs
Brief: Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language